Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov

Compared with cytotoxic chemotherapy, radiotherapy, and surgery, positive findings have been acquired through the approach of blocking the programmed cell death protein 1 (PD-1) pathway with antibodies that exert inhibitory effects on PD-1 or cell death protein ligand 1 (PD-L1). Results from clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Que, Yi, Hu, Yang, Hong, Dongchun, Zhang, Yizhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479973/
https://www.ncbi.nlm.nih.gov/pubmed/34583971
http://dx.doi.org/10.1136/jitc-2021-002920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479973/
https://www.ncbi.nlm.nih.gov/pubmed/34583971
http://dx.doi.org/10.1136/jitc-2021-002920

Ejemplares similares